Quantifying Treatment Effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial

Andrew A. Lover
doi: https://doi.org/10.1101/2020.03.22.20040949

Article usage

Article usage: March 2020 to July 2022

AbstractFullPdf
Mar 2020938002465
Apr 2020699701992
May 202016020338
Jun 20206230167
Jul 20207990207
Aug 20205730145
Sep 2020253060
Oct 2020181052
Nov 2020152066
Dec 2020154254
Jan 20212331294
Feb 2021185156
Mar 20212081057
Apr 2021150533
May 2021171444
Jun 2021161353
Jul 2021213543
Aug 20211861029
Sep 2021146233
Oct 2021114646
Nov 202197656
Dec 202172323
Jan 2022123923
Feb 2022136016
Mar 2022197418
Apr 2022133720
May 2022113121
Jun 20229009
Jul 20221203
Back to top
Posted March 27, 2020.
Download PDF
Data/Code
Email
Quantifying Treatment Effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial
Andrew A. Lover
medRxiv 2020.03.22.20040949; doi: https://doi.org/10.1101/2020.03.22.20040949
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area